
Lantern Pharma Investor Relations Material
Latest events

Q1 2025
Lantern Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Lantern Pharma Inc
Access all reports
Lantern Pharma Inc. is a clinical-stage biotechnology company focused on leveraging artificial intelligence and genomic data to develop precision oncology therapeutics. The company’s pipeline targets a range of cancers with the aim of enhancing treatment outcomes and reducing development risks. Lantern Pharma Inc. is headquartered in Dallas, Texas, and its shares are listed on the NASDAQ.
Key slides for Lantern Pharma Inc


Q1 2025
Lantern Pharma Inc


Q1 2025
Lantern Pharma Inc
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
LTRN
Country
🇺🇸 United States